Dr Sayuri Cheruvu, MB,BS | |
5340 Holy Cross Pkwy, Mishawaka, IN 46545-1470 | |
(574) 237-1328 | |
(574) 237-1348 |
Full Name | Dr Sayuri Cheruvu |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 18 Years |
Location | 5340 Holy Cross Pkwy, Mishawaka, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134357213 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RX0202X | Internal Medicine - Medical Oncology | 01080364A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
Unity Medical And Surgical Hospital | Mishawaka, IN | Hospital |
Memorial Hospital Of South Bend | South bend, IN | Hospital |
Elkhart General Hospital | Elkhart, IN | Hospital |
Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Michiana Hematology-oncology P C | 3375513419 | 12 |
News Archive
DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement.
Bisphenol A (BPA), an estrogen-like compound that has drawn increased scrutiny in recent years, has been linked to changes in thyroid hormone levels in pregnant women and newborn boys, according to a new study by researchers at the University of California, Berkeley.
Research from the Johns Hopkins Children's Center suggests that common language may also be the divide standing between mothers of critically ill newborns and the clinicians who care for them.
ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).
› Verified 5 days ago
Entity Name | Michiana Hematology-oncology P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619970183 PECOS PAC ID: 3375513419 Enrollment ID: O20040727001513 |
News Archive
DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement.
Bisphenol A (BPA), an estrogen-like compound that has drawn increased scrutiny in recent years, has been linked to changes in thyroid hormone levels in pregnant women and newborn boys, according to a new study by researchers at the University of California, Berkeley.
Research from the Johns Hopkins Children's Center suggests that common language may also be the divide standing between mothers of critically ill newborns and the clinicians who care for them.
ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sayuri Cheruvu, MB,BS Po Box 746092, Atlanta, GA 30374-6092 Ph: (574) 204-7803 | Dr Sayuri Cheruvu, MB,BS 5340 Holy Cross Pkwy, Mishawaka, IN 46545-1470 Ph: (574) 237-1328 |
News Archive
DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement.
Bisphenol A (BPA), an estrogen-like compound that has drawn increased scrutiny in recent years, has been linked to changes in thyroid hormone levels in pregnant women and newborn boys, according to a new study by researchers at the University of California, Berkeley.
Research from the Johns Hopkins Children's Center suggests that common language may also be the divide standing between mothers of critically ill newborns and the clinicians who care for them.
ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).
› Verified 5 days ago
Mini Sra, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Rafat H Ansari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-234-5123 Fax: 574-282-2813 | |
Dr. Elizabeth Marie Lauber, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5215 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-335-2521 Fax: 574-335-2262 | |
Margaret Ann Quate-operacz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3665 Park Pl W, Suite 300, Mishawaka, IN 46545 Phone: 574-607-4724 Fax: 574-607-4725 | |
Anandkumar M Koyani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 S Main St, Suite 109, Mishawaka, IN 46544 Phone: 574-256-0235 Fax: 574-256-0236 | |
Dr. Yufeng Kevin Wu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Ste 200, Mishawaka, IN 46545 Phone: 574-204-7252 Fax: 574-968-0468 |